Biocon Limited (BIOCON)

Name: Biocon Limited (BIOCON) — historial de estados financieros
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historial de ingresos, beneficios y flujo de caja según los estados financieros oficiales.

Healthcare · Wall Street (EE. UU.) · Última actualización: 2026-09-20

Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments.

Cifras clave

Capitalización bursátil: ₹627 billion
Ingresos (ejercicio cerrado en 2026-03-31): ₹167.8B
Beneficio neto: ₹3.9B
Margen bruto: 66.1%
Margen neto: 2.3%

Ver gráficos interactivos y estados completos →

Cuenta de resultados anual

Cuenta de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Ingresos totales	₹167.8B	₹150.5B	₹142.0B	₹109.3B
Beneficio bruto	₹110.9B	₹98.5B	₹92.9B	₹72.7B
Ingresos operativos (EBIT)	₹17.2B	₹16.3B	₹14.3B	₹16.3B
Ingresos netos	₹3.9B	₹10.1B	₹10.2B	₹4.6B

Fuente: informes públicos de la empresa (SEC). Verifique en SEC EDGAR antes de confiar en cualquier cifra.

Balances, flujos de caja, datos trimestrales y ratios completos en el visor interactivo de BIOCON. /companies/us/BIOCON

Empresas similares

La información de este sitio es solo educativa e informativa; no constituye asesoramiento de inversión. No se publican precios objetivo ni recomendaciones.

English version →Todas las acciones

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.